Status:
COMPLETED
Copeptin as a Diagnostic Marker in the Management of Neurosurgical Patients With Disturbance of Water Homeostasis
Lead Sponsor:
University Hospital, Basel, Switzerland
Collaborating Sponsors:
Kantonsspital Aarau
Conditions:
Pituitary Adenoma
Eligibility:
All Genders
15+ years
Brief Summary
Water imbalance and consecutive electrolyte disturbances are common in the postoperative course of neurosurgical patients after pituitary surgery. Diabetes insipidus (DI) may complicate the postoperat...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- All consecutive patients who undergo surgery for an intra- or suprasellar lesion, either by craniotomy or by transphenoidal resection.
Exclusion
Key Trial Info
Start Date :
October 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2013
Estimated Enrollment :
125 Patients enrolled
Trial Details
Trial ID
NCT01465672
Start Date
October 1 2011
End Date
December 1 2013
Last Update
May 20 2014
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Basel
Basel, Basel, Switzerland, 4031
2
Kantonsspital Aarau
Aarau, Switzerland